首页 | 本学科首页   官方微博 | 高级检索  
检索        

全蝎和蜈蚣的多肽粗提物对肝癌HepAD38细胞中HBV的抑制作用
引用本文:马青,杨扬,马韬,徐卫东,赵明.全蝎和蜈蚣的多肽粗提物对肝癌HepAD38细胞中HBV的抑制作用[J].江苏大学学报(医学版),2021,31(5):431-437.
作者姓名:马青  杨扬  马韬  徐卫东  赵明
作者单位:(1. 江苏大学药学院,江苏 镇江 212013; 2. 上海计划生育科学研究所,上海 200032; 3. 上海交通大学附属瑞金医院普外科,上海 200025)
摘    要:目的: 研究全蝎尾部多肽粗提物(peptide extract from scorpion tail,PEST)与蜈蚣头部多肽粗提物(peptide extract from centipede head, PECH)对肝癌细胞乙型肝炎病毒(Hepatitis B virus, HBV)合成的影响及其可能机制。方法:超滤法提取PEST与PECH。选取肝癌HepAD38和HepG2细胞,将其分组:对照组,用含10%胎牛血清的培养基培养;PEST组,不同浓度PEST(0.125、0.250、0.500和1.000 mg/mL)处理;PECH组,不同浓度PECH(0.125、0.250、0.500和1.000 mg/mL)处理;阳性对照组,拉米夫定或恩替卡韦或四环素处理。MTT法检测细胞活力,qRT PCR检测HepAD38细胞上清液HBV DNA含量。另取HepAD38细胞,分为PEST组(1 mg/mL PEST处理)、PECH组(1 mg/mL PECH处理)、对照组、阳性对照组和阴性对照组;ELISA法检测细胞上清液中HBsAg和HBeAg含量,qRT PCR检测HBV X、S、preC、P mRNA表达量,蛋白印迹法检测HBV核心蛋白(HBV core protein,HBc)表达。结果:PEST或PECH处理的肝癌细胞HepG2和HepAD38细胞活力均在70%以上;与对照组相比,PEST组(0.250、0.500和1.000 mg/mL)和PECH组(0.125、0.500和1.000 mg/mL)HBV DNA拷贝数明显降低(P均<0.05);与对照组相比,PEST组和PECH组HBsAg和HBeAg含量明显降低(P均<0.05),HBV P mRNA相对表达明显降低(P均<0.05),PEST组HBc表达几乎无差异,而PECH组HBc表达减少。结论:PEST和PECH在HepAD38细胞株中表现出抗HBV作用,可能与其抑制HBV P mRNA合成有关。

关 键 词:乙型肝炎病毒  全蝎  蜈蚣  多肽  HepAD38细胞  肝癌  
收稿时间:2020-05-13

Inhibition of Hepatitis B virus in liver cancer cells by preliminary peptide extracts of scorpion and centipede
MA Qing,YANG Yang,MA Tao,XU Weidong,ZHAO Ming.Inhibition of Hepatitis B virus in liver cancer cells by preliminary peptide extracts of scorpion and centipede[J].Journal of Jiangsu University Medicine Edition,2021,31(5):431-437.
Authors:MA Qing  YANG Yang  MA Tao  XU Weidong  ZHAO Ming
Institution:(1. Pharmacy College, Jiangsu University, Zhenjiang Jiangsu 212013; 2. Shanghai Institute of Planned Parenthood Research, Shanghai 200032; 3. Department of General Surgery, Ruijin Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200025, China)
Abstract:Objective: To explore the effects of scorpion peptide preliminary extract (peptide extract from scorpion tail, PEST) and the centipede preliminary peptide extract (peptide extract from centipede head, PECH) on Hepatitis B virus synthesis and potential mechanism in liver cancer cells. Methods: Ultrafiltration was used to extract PEST and PECH. HepAD38 and HepG2 cells were selected and divided into control group, cells were cultured with high sugar medium containing with 10% fetal bovine serum; PEST group, cells were treated with different concentrations (0.125, 0.250, 0.500 and 1.000 mg/mL) of PEST; PECH group, cells were treated with different concentrations (0.125, 0.250, 0.500,1.000 mg/mL) of PECH; positive control group, cells were treated with lamivudine or entecavir or tetracycline; MTT assay was used to detect cell viability. The qRT PCR was used to detect Hepatitis B virus DNA content in the supernatant of HepAD38 cells. In addition, HepAD38 cells were divided into PEST group (cells were treated with 1 mg/mL PEST), PECH group (cells were treated with 1 mg/mL PECH), control group, positive control group and negative group; HBsAg and HBeAg content were detected by ELISA; HBV X,S,preC,P mRNA relative expression level were detected by qRT PCR; Hepatitis B virus core protein synthesis was detected by Western blotting. Results: The cell viability of HepG2 and HepAD38 cells treated with PEST or PECH were both above 70%;compared with the control group, PEST(0.250, 0.500 and 1.000 mg/mL) or PECH (0.125, 0.500 and 1.000 mg/mL) group showed significantly decreased Hepatitis B virus DNA copy number (all P<0.05); compared with the control group, PEST or PECH group showed significantly lower content of HBsAg and HBeAg and expression level of Hepatitis B virus P mRNA (all P<0.05), PEST group had almost no effect on core protein expression, while PECH group decreased Hepatitis B virus core protein expression. Conclusion: PEST and PECH exerted anti Hepatitis B virus effect on HepAD38 cell, which may be related to its inhibition on P mRNA synthesis of Hepatitis B virus.
Keywords:
本文献已被 万方数据 等数据库收录!
点击此处可从《江苏大学学报(医学版)》浏览原始摘要信息
点击此处可从《江苏大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号